+Search query
-Structure paper
Title | Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodies. |
---|---|
Journal, issue, pages | Mol Cancer, Vol. 22, Page 150-150, Year 2023 |
Publish date | Aug 1, 2022 (structure data deposition date) |
Authors | Rodriguez, I. / Kocik-Krol, J. / Skalniak, L. / Musielak, B. / Wisniewska, A. / Ciesiolkiewicz, A. / Berlicki, L. / Plewka, J. / Grudnik, P. / Stec, M. ...Rodriguez, I. / Kocik-Krol, J. / Skalniak, L. / Musielak, B. / Wisniewska, A. / Ciesiolkiewicz, A. / Berlicki, L. / Plewka, J. / Grudnik, P. / Stec, M. / Siedlar, M. / Holak, T.A. / Magiera-Mularz, K. |
External links | Mol Cancer / PubMed:37679783 |
Methods | X-ray diffraction |
Resolution | 1.1 Å |
Structure data | PDB-8alx: |
Chemicals | ChemComp-ACT: ChemComp-GOL: ChemComp-HOH: |
Source |
|
Keywords | IMMUNE SYSTEM / PD-L1 / immunooncology |